Title |
Dengue virus non-structural protein 1: a pathogenic factor, therapeutic target, and vaccine candidate
|
---|---|
Published in |
Journal of Biomedical Science, July 2018
|
DOI | 10.1186/s12929-018-0462-0 |
Pubmed ID | |
Authors |
Hong-Ru Chen, Yen-Chung Lai, Trai-Ming Yeh |
Abstract |
Dengue virus (DENV) infection is the most common mosquito-transmitted viral infection. DENV infection can cause mild dengue fever or severe dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS). Hemorrhage and vascular leakage are two characteristic symptoms of DHF/DSS. However, due to the limited understanding of dengue pathogenesis, no satisfactory therapies to treat nor vaccine to prevent dengue infection are available, and the mortality of DHF/DSS is still high. DENV nonstructural protein 1 (NS1), which can be secreted in patients' sera, has been used as an early diagnostic marker for dengue infection for many years. However, the roles of NS1 in dengue-induced vascular leakage were described only recently. In this article, the pathogenic roles of DENV NS1 in hemorrhage and vascular leakage are reviewed, and the possibility of using NS1 as a therapeutic target and vaccine candidate is discussed. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Australia | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Scientists | 1 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 438 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 63 | 14% |
Student > Master | 56 | 13% |
Student > Ph. D. Student | 41 | 9% |
Researcher | 28 | 6% |
Student > Doctoral Student | 11 | 3% |
Other | 35 | 8% |
Unknown | 204 | 47% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 75 | 17% |
Medicine and Dentistry | 45 | 10% |
Immunology and Microbiology | 32 | 7% |
Agricultural and Biological Sciences | 23 | 5% |
Engineering | 12 | 3% |
Other | 37 | 8% |
Unknown | 214 | 49% |